Viraj Kariyawasam

8PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersSouth-East Asian languages (excl. Indonesian)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 08, 2026
Off-label upadacitinib 60 mg daily in the rescue of refractory ulcerative colitis: an open-labeled cohort study.

|Jan 22, 2026
Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy.

Aviv Pudipeddi, Thanaboon Chaemsupaphan, Arteen Arzivian

|Jan 06, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab.

Thanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin

|Oct 10, 2024
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.

Rupert W Leong, Anthony Sakiris, Arteen Arzivian

|Jan 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.

John David Chetwood, Yanna Ko, Aviv Pudipeddi

|Aug 24, 2023
Adolescents and young adults communicating with gastroenterologists: variation in inflammatory bowel disease clinical communication.

Neda Karimi, Annabelle Lukin, Alison R Moore

Pageof 2

Frequent Collaborators

7 joint publications

Rupert Wl Leong

3 joint publications

Thanaboon Chaemsupaphan

2 joint publications

John David Chetwood

2 joint publications

Aviv Pudipeddi